Plain-English translation of NCT03375619 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term follow-up study for people who have already received CAR-T cell therapy—a type of immunotherapy that trains your own immune cells to fight blood cancers like leukemia, lymphoma, and myeloma. Researchers want to follow you for up to 15 years after your treatment to see how long the therapy continues to work, whether any new cancers develop, and how you're doing overall.
CAR-T cell therapy is relatively new and powerful, but doctors need to understand what happens to patients years and years after treatment. By following patients long-term, researchers can spot any delayed side effects early, learn how durable the benefits are, and improve care for future patients receiving this treatment.
You likely qualify if…
You likely don't qualify if…
You'll be asked to return for check-in visits and answer questions about your health from 2 to 15 years after your CAR-T cell treatment. These visits may include blood tests and other routine monitoring to check whether your CAR-T cells are still present, whether your cancer is still in remission, and whether you're experiencing any long-term side effects. The study is designed to fit into your normal follow-up care with your doctor.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Medical College of Wisconsin
Enrollment target
~500 participants
Started
December 2017
Primary completion
January 2035
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Medical College of Wisconsin Clinical Cancer Center
Medical College of Wisconsin
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.